Two negatively charged invariant residues influence ligand binding and conformational dynamics of 14-3-3ζ.

14-3-3 protein conformational change fluorescence anisotropy limited trypsinolysis peptide interaction surface plasmon resonance

Journal

FEBS letters
ISSN: 1873-3468
Titre abrégé: FEBS Lett
Pays: England
ID NLM: 0155157

Informations de publication

Date de publication:
03 2020
Historique:
received: 25 07 2019
revised: 27 09 2019
accepted: 11 10 2019
pubmed: 7 11 2019
medline: 6 10 2020
entrez: 7 11 2019
Statut: ppublish

Résumé

14-3-3 proteins bind and modulate the activities of a wide variety of phosphoproteins. Crystal structures of 14-3-3 isoforms bound to phospholigands have identified several residues important for ligand binding. Here, we report the role of two invariant residues, D124 and E131, in peptide binding and peptide-induced conformational changes of the binding pocket. Surprisingly, the D124A mutation abrogates peptide binding, while the E131A mutation results in a twofold increase in peptide affinity. The mutants are less stable than the wild-type protein, and peptide binding restores native-like stability to the E131A mutant. This reversibility is lost in the more open structure of D124A. Based on these results, we infer that E131 is a regulator of protein plasticity and D124 is the guardian of the active site geometry.

Identifiants

pubmed: 31693753
doi: 10.1002/1873-3468.13662
doi:

Substances chimiques

14-3-3 Proteins 0
Ligands 0
YWHAZ protein, human 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

878-886

Informations de copyright

© 2019 Federation of European Biochemical Societies.

Références

Aitken A (2006) 14-3-3 proteins: a historic overview. Semin Cancer Biol 16, 162-172.
Fu H, Subramanian RR and Masters SC (2000) 14-3-3 PROTEINS : structure, function, and regulation. Annu Rev Pharmacol Toxicol 40, 617-647.
Hermeking H and Benzinger A (2006) 14-3-3 proteins in cell cycle regulation. Semin Cancer Biol 16, 183-192.
Yaffe MB, Rittinger K, Volinia S, Caron PR, Aitken A, Leffers H, Gamblin SJ, Smerdon SJ, Cantley LC and Street W (1997) The structural basis for 14-3-3: phosphopeptide Binding Specificity. Cell 91, 961-971.
Rittinger K, Budman J, Xu J, Volinia S, Cantley LC, Smerdon SJ, Gamblin SJ and Yaffe MB (1999) Structural analysis of 14-3-3 phosphopeptide complexes identifies a dual role for the nuclear export signal of 14-3-3 in ligand binding. Mol Cell 4, 153-166.
Coblitz B, Wu M, Shikano S and Li M (2006) C-terminal binding: an expanded repertoire and function of 14-3-3 proteins. FEBS Lett 580, 1531-1535.
Zhang L, Wang H, Liu D, Liddington R and Fu H (1997) Raf-1 kinase and exoenzyme S interact with 14-3-3ζ through a common site involving lysine 49. J Biol Chem 272, 13717-13724.
Zhai J, Lin H, Shamim M, Schlaepfer WW and Cañete-Soler R (2001) Identification of a Novel Interaction of 14-3-3 with p190RhoGEF. J Biol Chem 276, 41318-41324.
Du Y, Khuri FR and Fu H (2008) A homogenous luminescent proximity assay for 14-3-3 interactions with both phosphorylated and nonphosphorylated client peptides. Curr Chem Genomics 2, 40-47.
Petosa C, Masters SC, Bankston LA, Pohl J, Wang B, Fu H and Liddington RC (1998) 14-3-3ζ binds a phosphorylated raf peptide and an unphosphorylated peptide via its conserved amphipathic groove. J Biol Chem 273, 16305-16310.
Yang X, Lee WH, Sobott F, Papagrigoriou E, Robinson CV, Grossmann JG, Sundstrom M, Doyle DA and Elkins JM (2006) Structural basis for protein-protein interactions in the 14-3-3 protein family. Proc Natl Acad Sci 103, 17237-17242.
Lees JG, Miles AJ, Wien F and Wallace BA (2006) A reference database for circular dichroism spectroscopy covering fold and secondary structure space. Bioinformatics 22, 1955-1962.
Woodcock JM, Goodwin KL, Sandow JJ, Coolen C, Perugini MA, Webb AI, Pitson SM, Lopez AF and Carver JA (2018) Role of salt bridges in the dimer interface of 14- 3-3ζ in dimer dynamics, N-terminal α-helical order, and molecular chaperone activity. J Biol Chem 293, 89-99.
Morrison DK (2009) The 14-3-3 proteins: integrators of diverse signalling cues that impact cell fate and cancer development. Trends Cell Biol 19 , 16-23.
Gardino AK, Smerdon SJ and Yaffe MB (2006) Structural determinants of 14-3-3 binding specificities and regulation of subcellular localization of 14-3-3 ligand complexes: a comparison of X-ray crystal structures of all human 14-3-3 isoforms. Semin Cancer Biol 16, 173-182.
Obsil T, Ghirlando R, Klein DC, Ganguly S and Dyda F (2002) Crystal Structure of the 14-3-3ζ: serotonin N-Acetyltransferase Complex. Cell 105, 257-267.
Woodcock JM, Murphy J, Stomski FC, Berndt MC and Lopez AF (2003) The dimeric versus monomeric status of 14-3-3ζ is controlled by phosphorylation of Ser58 at the dimer interface. J Biol Chem 278, 36323-36327.

Auteurs

Kruti Modi (K)

Protein Interactome Lab for Structural and Functional Biology, Advanced Centre for Treatment, Research and Education in Cancer, Kharghar, Navi Mumbai, India.

Somavally Dalvi (S)

Protein Interactome Lab for Structural and Functional Biology, Advanced Centre for Treatment, Research and Education in Cancer, Kharghar, Navi Mumbai, India.

Prasanna Venkatraman (P)

Protein Interactome Lab for Structural and Functional Biology, Advanced Centre for Treatment, Research and Education in Cancer, Kharghar, Navi Mumbai, India.
BARC Training School Complex, Homi Bhabha National Institute, Mumbai, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH